Boston Scientific (BSX) PT Raised to $42 at Citi, Following Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $41.72 +0.34%
Rating Summary:
31 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 15 | New: 34
Rating Summary:
31 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 15 | New: 34
Join SI Premium – FREE
Citi analyst Joanna Wuensch raised the price target on Boston Scientific (NYSE: BSX) to $42.00 (from $40.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Starbucks (SBUX) PT Lowered to $105 at UBS as Shares Already Reflect Improved Momentum
- Teck Resources Ltd (TECK-B:CN) (TECK) PT Raised to Cdn$115 at UBS
- Freedom Broker Upgrades Constellation Brands (STZ) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Citi, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
